DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded to “Buy” by StockNews.com

StockNews.com upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a hold rating to a buy rating in a research report sent to investors on Monday.

XRAY has been the subject of a number of other research reports. Robert W. Baird lowered their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Needham & Company LLC reduced their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Friday. Evercore ISI reduced their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Barrington Research restated an “outperform” rating and set a $36.00 price target on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Finally, Stifel Nicolaus reduced their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, July 18th. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has an average rating of “Moderate Buy” and an average target price of $32.67.

DENTSPLY SIRONA Trading Up 1.3 %

NASDAQ XRAY opened at $23.61 on Monday. DENTSPLY SIRONA has a 1-year low of $22.85 and a 1-year high of $37.60. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. The stock has a 50-day moving average of $25.22 and a 200-day moving average of $26.43. The firm has a market cap of $4.79 billion, a PE ratio of -27.45, a price-to-earnings-growth ratio of 1.12 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The company had revenue of $984.00 million during the quarter, compared to the consensus estimate of $993.61 million. During the same period last year, the firm posted $0.51 EPS. The company’s revenue was down 4.3% on a year-over-year basis. As a group, sell-side analysts forecast that DENTSPLY SIRONA will post 1.98 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in XRAY. UMB Bank n.a. grew its stake in shares of DENTSPLY SIRONA by 430.3% in the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after buying an additional 753 shares during the last quarter. LRI Investments LLC grew its stake in shares of DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after buying an additional 564 shares during the last quarter. Rothschild Investment LLC purchased a new stake in shares of DENTSPLY SIRONA in the 2nd quarter worth approximately $32,000. Allworth Financial LP grew its stake in shares of DENTSPLY SIRONA by 40.2% in the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock worth $59,000 after buying an additional 625 shares during the last quarter. Finally, Central Pacific Bank Trust Division purchased a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth approximately $64,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.